We have our own point of view on the people, technologies, and conversations that will shape the future.
The Seven Generative AI Building Blocks for the Next Generation of Consumer Technology Companies
OpenAI’s ChatGPT reached 100 million monthly active users just two months after launch, setting the new standard for the fastest-growing consumer application in history. The landmark achievement underscored the strength of generative AI’s pull in consumer markets—surpassing even the breakthroughs of the internet and smartphones.
Our Investment in Typeface: Generative AI at Enterprise Speed and Scale
Since the advent of the internet, few technological advances have garnered as much attention and enthusiasm as quickly as generative AI. The technology has seen a meteoric rise, skyrocketing from a relatively unknown status to nearly ubiquitous interest, capturing our collective attention and imaginations along the way.
Software Will Supercharge Developer Productivity: Why We Are Excited About DX
Software developers spend their days chasing the elusive “flow state:” headphones on, Slack notifications paused, dev environment humming along, context switching to a minimum, and delivering a significant amount of valuable code and/or solving a hard problem. The unfortunate reality is developer flow is constantly interrupted by toil: faulty environments, flaky tests, slow builds, cross-team dependencies, and the like.
The code that runs the world today is rarely written from scratch. In 2021, developers borrowed more than 2.2 trillion open source packages or components from third-party ecosystems. 99% of codebases contain open-source code, and between 85% to 97% of enterprises leverage open-source software.
Developers have become increasingly powerful decision makers and influencers within organizations, with purchasing powers of their own and dedicated budgets—particularly in light of the explosive growth of GenAI.
Predictive and generative AI are entering many new applications. At Menlo Ventures, we are especially excited about applications for AI in drug discovery and development, specifically when new technology can directly address a major unmet need.
Riva Health founders Tuhin Sinha and Dag Kittlaus discuss their critical mission to revolutionize cardiovascular healthcare; their long histories with Menlo partners Greg Yap and Shawn Carolan; how they were introduced to each other; and the whirlwind journey to FDA approval.
Developing an elevator pitch is a powerful exercise for helping entrepreneurs sharpen their thinking around a potential new business idea. Coming up with innovative ideas is a challenge in itself, and founders are often caught spinning their wheels, struggling to bring clarity and focus to their vision.